Clinical Trial: Phase 3 Randomized Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07835581) titled 'Phase 3 Randomized Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation' on Sept. 16.

Brief Summary: This study will evaluate the efficacy and safety of tegoprubart compared with tacrolimus in adult participants undergoing first kidney transplantation.

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Kidney Transplant Rejection

Intervention: DRUG: Tegoprubart

Tegoprubart administered via IV infusion

DRUG: Tacrolimus

Tacrolimus administered orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eledon Pharmaceuticals

Disclaimer: Curated by HT Syndication....